No........not true. If they have partnered in the marketing and sales of the drug, then all that has to be inked prior to any news releases. The drug is efficacious period. The rare autoimmune issue can be dealt with in the dosing over time. My take...the drug is approved with labeling precautions. Hospitals are in need of a Hep B vax.